4-aminopyrimidine compound, its preparation method and medical application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2020-05-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicines, and in particular relates to a 4-aminopyrimidine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and their use as Bruton's tyrosine kinase inhibitors.
[0002] technical background
[0003] Bruton's tyrosine kinase (BTK) is a member of the Tec family of non-receptor tyrosine protein kinases. It consists of 659 amino acids and contains multiple domains, such as Pleckstrin homology (PH) domain, Tec homology (TH ) domain, Src homology 3 (SH3) domain, SH2 and SH1 domains (Future Med Chem, 2014, 6(6):675-695). Studies have shown that BTK, as an important part of the B cell receptor (BCR) signal transduction pathway, plays an extremely important role in many physiological processes such as the development, maturation, differentiation and proliferation of B cells (Nature, 1993, 361 (6409 ):226-233).
[0004] Precise regulation of BTK is crucial to maintain the normal physi...